An overview of epidemic models with phase transitions to absorbing states running on top of complex networks
1Departamento de Física, Universidade Federal de Lavras, Caixa postal 3037, CEP:37200-900, Lavras, Minas Gerais, Brazil.
Abstract:
Dynamical systems running on the top of complex networks have been extensively investigated for decades. But this topic still remains among the most relevant issues in complex network theory due to its range of applicability. The contact process (CP) and the susceptible-infected-susceptible (SIS) model are used quite often to describe epidemic dynamics. Despite their simplicity, these models are robust to predict the kernel of real situations. In this work, we review concisely both processes that are well-known and very applied examples of models that exhibit absorbing-state phase transitions. In the epidemic scenario, individuals can be infected or susceptible. A phase transition between a disease-free (absorbing) state and an active stationary phase (where a fraction of the population is infected) are separated by an epidemic threshold. For the SIS model, the central issue is to determine this epidemic threshold on heterogeneous networks. For the CP model, the main interest is to relate critical exponents with statistical properties of the network.
More Related Videos
10:11Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
Published on: September 27, 2014
10:44Inherent Dynamics Visualizer, an Interactive Application for Evaluating and Visualizing Outputs from a Gene Regulatory Network Inference Pipeline
Published on: December 7, 2021
Related Concept Videos
Steps in Outbreak Investigation
Causality in Epidemiology
Exponential Equations for Modeling Growth
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Phase Transitions
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
